Clinical Trials List
2022-01-01 - 2024-07-31
Phase III
Recruiting11
ICD-10C68.9
Malignant neoplasm of urinary organ, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9189.9
Malignant neoplasm of urinary organ, site unspecified
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yu-Chieh Tsai 未分科
- Yeong-Shiau Pu 未分科
- JHE-CYUAN GUO 未分科
- CHUNG-HSIN CHEN 未分科
- Ying-Chun Shen 未分科
- FU-JEN HSUEH 未分科
- - - 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- See-Tong Pang 未分科
- Yuan-Cheng Chu 未分科
- Yung-Chia Kao 未分科
- Hong-Cheng Gan 未分科
- Yung-Chang Lin 未分科
- 張境夫 未分科
- I-hung Shao 未分科
- Po-Jung Su 未分科
- 沈鼎文 未分科
- 林柏宏 未分科
- 黃亮鋼 未分科
- 黃文冠 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Rei Yang Division of Hematology & Oncology
- Yi-Huei Chang Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- 謝德鈞 Division of Hematology & Oncology
- Po-Fan Hsieh Division of Urology
- Yu-De Wang Division of Urology
- Han Chang Division of General Surgery
- Chi-Ping Huang Division of Urology
- 陳冠亨 Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Chao-Hsiang Chang Division of Urology
- Po-Jen Hsiao Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- 蔡禮賢 Division of Urology
- 賴俊佑 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Ping Lin 未分科
- 陳威任 未分科
- William Huang 未分科
- Yen-Hwa Chang 未分科
- Tzu-Hao Huang 未分科
- Chueh-Chuan Yen 未分科
- 潘競成 未分科
- Yi-Hsiu Huang 未分科
- Chih-Chieh Lin 未分科
- Jiun-I Lai 未分科
- Tzu-chun Wei 未分科
- Mu-Hsin Chang 未分科
- 沈書慧 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Che-Yuan Hu Division of Urology
- Jiann-Hui Ou Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Urology
- 楊舜如 Division of Hematology & Oncology
- Kuan-Yu Wu Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳鴻毅 未分科
- HANG HUONG LING 未分科
- Pei-Hung Chang Division of Hematology & Oncology
- 張悅詩 Division of Hematology & Oncology
- 劉冠麟 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jian-Ri Li Division of Urology
- 林雁婷 Division of Radiology
- 梅承恩 Division of Urology
- 廖博崎 Division of Urology
- Cheng-Kuang Yang Division of Urology
- Chuan-Shu Chen Division of Urology
- Cheng-Che Chen Division of Urology
- 張瓈文 Division of Urology
- Shian-Shiang Wang Division of Urology
- Chia-Yen Lin Division of Urology
- 洪晟鈞 Division of Urology
- JU-CHUAN HU Division of Urology
- 裘坤元 未分科
- 熊小澐 未分科
- 王樹吉
- 盧嘉文 未分科
- 賴谷順 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
55 participants
-
Global
709 participants
